Myology research highlights
RSS feedMechanisms and future treatments for myasthenia gravis debated at International Society of Neuroimmunology (ISNI) congress
Supported by AFM-Telethon, the 15th edition of the International Society of Neuro-immunology congress was held online from November 8 to 12, 2021. It was co-chaired by Prof. Sonia Berrih-Aknin, from the Institute of Myology. During a session dedicated to myasthenia gravis, in its communication, the Rozen Le Panse team: reminded that this complex disease of … [Read more]
Early muscle damage in Glycogenosis type IIIa
Glycogenosis type IIIa is a deficiency in a debranching enzyme. It initially results in hepatic disorders but can classically lead to muscle disorders and increased fatigue from the third decade of life. A muscle imaging study, supplemented by a serie of functional tests, was carried out in the United States in 17 sick children and … [Read more]
Autoimmune neurological complications after Covid-19 vaccination remain exceptional
German specialists have identified 21 autoimmune neurological complications in their respective canton that occurred between March 1 and June 1, 2021 after Covid-19 vaccination in the 232,603 inhabitants vaccinated. They counted: sinus cerebral thrombophlebitis (3); demyelinating diseases of the central nervous system (8); dysimmune neuropathies (4); myositis (3); myasthenia gravis; large cell cerebral arteritis; limbic … [Read more]
Continuous non-invasive ventilation may be an alternative to tracheostomy ventilation
A significant number of neuromuscular patients with severe respiratory impairment are ventilated invasively, most often by means of a tracheostomy. An international study compiled data from 19 centers offering an alternative ventilation mode based on the continuous use of non-invasive ventilation coupled with insufflation-exsufflation maneuvers: the data, directly collected from the centers or through their … [Read more]
Italian observation confirms the involvement of the p.S85C variant in distal myopathy linked to the MATR3 gene
Distal myopathy with vocal cord palsy (or VCPDM) has only been described in twelve families around the world, including one in France. VCPDM belongs to the group of multisystem proteinopathies. Italian clinicians report the observation of a 40-year-old woman fulfilling the diagnostic criteria for this ultra-rare disease: the clinical picture shows steppage and rhinolalia, without … [Read more]
Images suggesting normal pressure hydrocephalus are frequently found in DM1
Japanese researchers analyzed brain MRI scans of 112 patients with DM1 and compared them to 50 brain MRI scans of controls. From the study of the z-Evans index, a recently developed parameter, they conclude that: dilation of the ventricles and sylvian valleys is frequent in DM1, even at a presymptomatic stage; these images are comparable … [Read more]
A more severe subtype of antisynthetase syndrome
Antisynthetase syndrome is part of the inflammatory myopathies (or myositis) known as “overlapping”. Chinese clinicians retrospectively studied a cohort of 113 adults with this form of myositis but free from any neoplastic process and rheumatic disease. 25 of them had flare-ups or inflammation more frequently, on average 1.12 times per year; this subgroup was at … [Read more]
A specific metabolic profile probably useful as a biomarker in SMA
Whether it is to specify the different categories of SMA or to monitor the progress of treated patients, there is still a lack of biomarkers. German researchers have developed and tested a new approach based on the study of the metabolome in urine proton spectrometry. In their study: twenty-nine patients with SMA and naïve to … [Read more]
Muscular dystrophy: the challenges of cell transplantation
Cell transplantation has been considered a possible treatment strategy for muscular dystrophy for decades, yet there have been more failures than successes, if not encouraging results so far. In this review of the literature, the authors briefly retrace the history of cell transplantation and describe the characteristics specific to skeletal muscle, and dystrophic skeletal muscle … [Read more]
SMA type 1: the results of the STR1VE-EU trial confirm the efficacy of Zolgensma
The STR1VE-EU trial evaluated the safety and efficacy of a single intravenous infusion of Zolgensma (onasemnogene abeparvovec) in 33 infants with SMN1-related proximal spinal muscular atrophy (SMA) type 1, presenting one or two copies of the SMN2 gene and aged under 6 months. The results of this trial, published in October 2021, show that: 97% … [Read more]